The environmental health survey is carried out in collaboration between the Institute of Environmental Medicine at Karolinska Institutet and the Statistics Sweden, on behalf of the Public Health Agency of Sweden. The study has been conducted in 1999, 2007 and 2015. The National environment health survey 2007 (NMHE 07) was sent to 43905 randomly selected persons in the hole country. The target population were everyone aged 18-80 living in Sweden during the last five years. Statistics Sweden (SCB) in association with occupation and environment- medicine (AMM) at Stockholm county has and sent out the questionnaires. They also have sent out reminders and transformed answered questionnaires to data files. SCB has completed answered questionnaires with register data and unidentified the data file. The investigation was approved by the Regional ethical committee in Stockholm. In order to made follow up studies possible, SCB has a code-key making it possible to identify participants in the future. NMHE 07 has been constructed so that answers from the questionnaire is possible to compare with NMHE 99. A vast majority of the questions are the same as the questions used 1999. The questionnaire has also been updated with 32 questions within new areas such as life-quality, sunhabits, telefonia etc. The questionnaire was answered by 25 935 individuals, representing a response rate of 59%. Purpose: The aim was to chart environmental exposure and environmental illness in the adult population
Occupational Health and Environmental Health
DRUGS INTENDED FOR HUMAN OR VETERINARY USE, PRESENTED IN THEIR FINISHED DOSAGE FORM
INHALING AND EXHALING THE SMOKE OF BURNING TOBACCO
CONCERNED WITH THE PREVENTION AND CONTROL OF DISEASE AND DISABILITY, AND THE PROMOTION OF THE PHYSICAL AND MENTAL HEALTH OF THE POPULATION
CONTAMINATION OF THE AIR BY TOBACCO SMOKE
Natural and man-made environments and their impact on public health.
Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are CASE-CONTROL STUDIES; COHORT STUDIES; and CROSS-SECTIONAL STUDIES.
Diseases involving the RESPIRATORY SYSTEM.
Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.
Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
A general term for the complete or partial loss of the ability to hear from one or both ears.
An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent.
Regular course of eating and drinking adopted by a person or animal.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Any sound which is unwanted or interferes with HEARING other sounds.
A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents.
A pathological accumulation of air in tissues or organs.
Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions.
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
The presence of contaminants or pollutant substances in the air (AIR POLLUTANTS) that interfere with human health or welfare, or produce other harmful environmental effects. The substances may include GASES; PARTICULATE MATTER; or volatile ORGANIC CHEMICALS.
The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.
Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.
Visible gaseous suspension of carbon and other particulate matter emitted from burning substances.
Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
INFRASTRUCTURE FOR WATER SUPPLY, CONTAINMENT AND TREATMENT. DOES NOT INCLUDE INFRASTRUCTURE FOR TRANSPORT
documentation/Miljöhälsorapport 2009.pdf
documentation/Nationella miljöhälsoenkäten 2007 - enkät.pdf